Category: Biomarkers and Laboratory Measurements
Creatine Kinase Test
In Duchenne Muscular Dystrophy (DMD), a Creatine Kinase (CK) test serves as a highly sensitive initial screening tool that detects ongoing, severe muscle damage. While a high CK level does not pinpoint DMD exclusively, abnormally elevated results are the primary red flag that directs physicians to order definitive genetic testing.
The Meaning of CK Levels in Duchenne • The Role of Dystrophin: DMD is caused by a genetic mutation that blocks the production of a vital protein called dystrophin. Without dystrophin, muscle cell membranes are incredibly fragile. Normal daily movement creates microscopic tears that the body cannot properly repair. • Massive Elevations: Because of constant, progressive muscle breakdown, children with DMD showcase baseline CK levels that are 50 to 200 times higher than normal. This means counts frequently span from 10,000 U/L to over 35,000 U/L. • Early Warning Sign: These severe elevations are identifiable immediately at birth or during early infancy, often long before outward clinical symptoms like developmental or motor delays surface. • Fluctuation and Trajectory: CK levels typically peak between the ages of 2 and 5. After this peak, the values systematically decline by roughly 25% each year. This decrease happens because functioning muscle tissue is progressively replaced by fat and scar tissue, leaving fewer intact muscle cells behind to leak the enzyme.
- Abbreviation:
- Creatine Kinase Testing
- Updated November 4, 2026